[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363471-105":59,"doc-detail-363471-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","real-world-trends-in-diagnosis-treatment-and-survival-of-nonsmall-cell-lung-cancer-in-vietnam-research-study","Real-world trends in diagnosis, treatment, and survival of non–small cell lung cancer in Vietnam - Research study","","Evidence on how non–small cell lung cancer (NSCLC) management and outcomes change over time in low- and middle-income settings is limited. This study assessed longitudinal real-world NSCLC trends at a provincial oncology center in Vietnam for more than six years. A retrospective cohort of 3,087 histologically confirmed patients evaluated stage at diagnosis, molecular testing uptake, first-line treatment patterns, and overall survival using Kaplan–Meier and Cox models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/real-world-trends-in-diagnosis-treatment-and-survival-of-nonsmall-cell-lung-cancer-in-vietnam-research-study/363471/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/real-world-trends-in-diagnosis-treatment-and-survival-of-nonsmall-cell-lung-cancer-in-vietnam-research-study/363471.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about NSCLC in Vietnam?","Question",{"text":112,"@type":113},"The study evaluates temporal, real-world changes in NSCLC stage at diagnosis, molecular testing use, treatment patterns, and survival outcomes over more than six years in Vietnam.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was overall survival estimated and compared?",{"text":117,"@type":113},"Overall survival was estimated using the Kaplan–Meier method and compared across diagnosis periods with log-rank tests.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main survival-related and practice-related trends reported?",{"text":121,"@type":113},"Early-stage disease increased, molecular testing uptake rose (peaking in 2022), targeted therapy and immunotherapy use increased, and median overall survival improved from 2018 to 2023–2024. Diagnosis in 2021–2024 was independently associated with lower mortality than 2018–2020.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363471,1791478998,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Pham etal. BMC Cancer (2026) 26:664 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15982-8](https://doi.org/10.1186/s12885-026-15982-8)  \nRESEARCH Open Access  \nReal-world trends in diagnosis, treatment, and survival of non–small cell lung cancer in Vietnam  \nVinh Hung Pham1, Dinh Chinh Duong2, Viet Binh Nguyen 1, Huyen Nga Do3, Khanh Toan Nguyen 1*,  \nThi Thuy My Nguyen1, Thi Huong Pham1,4, Van Lam Ngo1, Van Tuan Nguyen2, Muoi Dang Ho2, Khanh Hung Truong1, Ba Duc Ho1 and Van Nhat Nguyen1  \nAbstract  \nBackground Evidence describing temporal changes in disease stage, molecular testing, treatment patterns, and survival outcomes in non–small cell lung cancer (NSCLC) from low-and middle-income countries remains scarce. We assessed longitudinal real-world trends in NSCLC management and outcomes at a provincial oncology center in Vietnam over more than six years.  \nMethods This retrospective observational study included consecutive adults with histologically confirmed NSCLC treated at Nghe An Oncology Hospital, Vietnam between January 2018 and August 2024 (n = 3,087) . Trends in stage at diagnosis (AJCC 8th edition), biomarker testing uptake (primarily epidermal growth factor receptor [EGFR]; limited anaplastic lymphoma kinase [ALK]), and first-line treatment modalities were evaluated. Overall survival (OS) was estimated using the Kaplan–Meier method and compared across diagnosis periods using log-rank tests. Multivariable Cox proportional hazards models were used to identify independent prognostic factors.  \nResults The median age was 64 years (range, 24–97), 73. 5% were male, 71. 6% had an Eastern Cooperative Oncology Group (ECOG) performance status of 0–1, and adenocarcinoma accounted for 77. 0% of cases. The proportion of early-stage disease (stage I–II) increased from 3. 1% in 2018 to 9. 8% in 2023–2024, while stage III disease declined from 33 . 3% to 20 .4% . Molecular testing uptake increased from 28. 7% to a peak of 65 . 1% in 2022 and remained approximately 60% thereafter. Use of first-line targeted therapy rose from 7.7% to 20.8%, and immunotherapy from 0% to 2. 5% . Median OS improved from 12.0 months in 2018 to 21.7 months in 2023–2024 (log-rank p \u003C 0. 001) . Diagnosis during 2021–2024 was independently associated with lower mortality compared with 2018–2020 (adjusted HR 0 . 80, 95% CI 0.73–0. 87) .  \nConclusions Substantial improvements in diagnosis, molecular testing, and treatment adoption were observed overtime and were associated with significantly improved survival in a large real-world Vietnamese NSCLC cohort. Keywords Non–small cell lung cancer, Real-world data, Temporal trends, Molecular testing, Survival outcomes, Vietnam  \n*Correspondence:  \nKhanh Toan Nguyen  \n[nguyenkhanhtoan15.10@gmail.com](nguyenkhanhtoan15.10@gmail.com)  \n1Nghe An Oncology Hospital, Nghe An Province, Vietnam  \n2Vinh Medical University, Vinh City, Vietnam 3Vietnam National Cancer Hospital, Hanoi, Vietnam 4Hanoi Medical University, Ha Noi City, Vietnam  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://","cbCain3qYxME7Y5p","https://ap.wps.com/l/cbCain3qYxME7Y5p","pdf",1442921,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What question does the study address about NSCLC in Vietnam?\",\"answer\":\"The study evaluates temporal, real-world changes in NSCLC stage at diagnosis, molecular testing use, treatment patterns, and survival outcomes over more than six years in Vietnam.\"},{\"question\":\"How was overall survival estimated and compared?\",\"answer\":\"Overall survival was estimated using the Kaplan–Meier method and compared across diagnosis periods with log-rank tests.\"},{\"question\":\"What were the main survival-related and practice-related trends reported?\",\"answer\":\"Early-stage disease increased, molecular testing uptake rose (peaking in 2022), targeted therapy and immunotherapy use increased, and median overall survival improved from 2018 to 2023–2024. Diagnosis in 2021–2024 was independently associated with lower mortality than 2018–2020.\"}]","Real-world trends in diagnosis, treatment, and survival of non–small cell lung cancer in Vietnam - Research study | PDF",1790151346,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c210ce1e99024f54fef57bb4f0ab4224.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f4776c8c3f8a4eb354e9d34ec82f7a0.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc2cb7adf5a25df8642c290efe1753d3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c46298a940516c4acff36431c89d891.webp",980,1306]